Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

January 16, 2022

Differential diagnosis of hereditary anemias from a fraction of blood drop by digital holography and hierarchical machine learning.

Biosensors & Bioelectronics
Pasquale MemmoloPietro Ferraro
January 16, 2022

Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.

Journal of Clinical Pharmacy and Therapeutics
Erin MilnerDavid Bookstaver
January 15, 2022

Congenital junctional ectopic tachycardia in the paediatric emergency department.

Cardiology in the Young
Danyal MemonMathew Varghese
January 15, 2022

Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.

Journal of the American College of Cardiology
Annabelle Santos VolgmanEmelia J Benjamin
January 15, 2022

Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week.

Journal of the American College of Cardiology
Alessandro MantovaniGiovanni Targher
January 15, 2022
Case Report

Serpentine Thrombus in Right Atrium: A Tell-Tale Sign of Venous Thromboembolism.

Vidyashree HulkotiDhruv Talwar
January 15, 2022

Erratum: Corrigendum to: Atrial flutter with flecainide-induced 1:1 conduction at a rate <200 b.p.m. at rest: a case report.

European Heart Journal. Case Reports
Sotirios Dardas, Asif Khan
January 15, 2022

Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial.

Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Marc W DeyellJohn L Sapp
January 14, 2022

Patients with low-voltage electric shock referred to an Emergency Department.

Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
Trude Beathe SvendsenLars Petter Bjørnsen
January 14, 2022

Electrophysiologic effects of sacubitril in different arrhythmia models.

European Journal of Pharmacology
Christian EllermannGerrit Frommeyer
January 14, 2022

Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis: Amiodarone-induced hypothyroidism epidemiology.

Trends in Cardiovascular Medicine
Keivan MohammadiHassan Rezvanian
January 14, 2022

QTc prolongation in patients with COVID-19: a retrospective chart review.

Translational and Clinical Pharmacology
Suphannika Prateepjarassaeng PornwattanakaveeNattawut Leelakanok
January 14, 2022

Neuroprotective role of Diosgenin, a NGF stimulator, against Aβ (1-42) induced neurotoxicity in animal model of Alzheimer's disease.

Metabolic Brain Disease
Swati SomSivasankaran Ponnusankar
January 14, 2022

Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma.

Cancer Chemotherapy and Pharmacology
Xi-Zhi WenXing Zhang

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused by a partial deletion of chromosome 22. Symptoms include heart defects, poor immune system function, a cleft palate, complications related to low levels of calcium in the blood, and delayed development. Discover the latest research on this disease here.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.


Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.


Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.


An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved